Literature DB >> 19843869

p27Kip1 stabilization is essential for the maintenance of cell cycle arrest in response to DNA damage.

Myriam Cuadrado1, Paula Gutierrez-Martinez, Aneta Swat, Angel R Nebreda, Oscar Fernandez-Capetillo.   

Abstract

One of the current models of cancer proposes that oncogenes activate a DNA damage response (DDR), which would limit the growth of the tumor in its earliest stages. In this context, and in contrast to studies focused on the acute responses to a one-time genotoxic insult, understanding how cells respond to a persistent source of DNA damage might become critical for future studies in the field. We here report the discovery of a novel damage-responsive pathway, which involves p27(Kip1) and retinoblastoma tumor suppressors and is only implemented after a persistent exposure to clastogens. In agreement with its late activation, we show that this pathway is critical for the maintenance, but not the initiation, of the cell cycle arrest triggered by DNA damage. Interestingly, this late response is independent of the canonical ataxia telangiectasia mutated-dependent and ataxia telangiectasia mutated and Rad3-related-dependent DDR but downstream of p38 mitogen-activated protein kinase. Our results might help to reconcile the oncogene-induced DNA damage model with the clinical evidence that points to non-DDR members as the most important tumor suppressors in human cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19843869      PMCID: PMC3594702          DOI: 10.1158/0008-5472.CAN-09-0729

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

Review 1.  CDK inhibitors: positive and negative regulators of G1-phase progression.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 11.361

2.  Genomic instability in mice lacking histone H2AX.

Authors:  Arkady Celeste; Simone Petersen; Peter J Romanienko; Oscar Fernandez-Capetillo; Hua Tang Chen; Olga A Sedelnikova; Bernardo Reina-San-Martin; Vincenzo Coppola; Eric Meffre; Michael J Difilippantonio; Christophe Redon; Duane R Pilch; Alexandru Olaru; Michael Eckhaus; R Daniel Camerini-Otero; Lino Tessarollo; Ferenc Livak; Katia Manova; William M Bonner; Michel C Nussenzweig; André Nussenzweig
Journal:  Science       Date:  2002-04-04       Impact factor: 47.728

3.  Characterization of the 5'flanking region of the human Chk1 gene: identification of E2F1 functional sites.

Authors:  Laura Carrassa; Massimo Broggini; Faina Vikhanskaya; Giovanna Damia
Journal:  Cell Cycle       Date:  2003 Nov-Dec       Impact factor: 4.534

Review 4.  H2AX: the histone guardian of the genome.

Authors:  Oscar Fernandez-Capetillo; Alicia Lee; Michel Nussenzweig; André Nussenzweig
Journal:  DNA Repair (Amst)       Date:  2004 Aug-Sep

5.  ATR and ATRIP: partners in checkpoint signaling.

Authors:  D Cortez; S Guntuku; J Qin; S J Elledge
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

6.  UV-induced ataxia-telangiectasia-mutated and Rad3-related (ATR) activation requires replication stress.

Authors:  Irene M Ward; Kay Minn; Junjie Chen
Journal:  J Biol Chem       Date:  2004-01-23       Impact factor: 5.157

7.  Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control.

Authors:  C Deng; P Zhang; J W Harper; S J Elledge; P Leder
Journal:  Cell       Date:  1995-08-25       Impact factor: 41.582

8.  Radiation-induced cell cycle arrest compromised by p21 deficiency.

Authors:  J Brugarolas; C Chandrasekaran; J I Gordon; D Beach; T Jacks; G J Hannon
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

9.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.

Authors:  M Pagano; S W Tam; A M Theodoras; P Beer-Romero; G Del Sal; V Chau; P R Yew; G F Draetta; M Rolfe
Journal:  Science       Date:  1995-08-04       Impact factor: 47.728

10.  The CDK regulates repair of double-strand breaks by homologous recombination during the cell cycle.

Authors:  Yael Aylon; Batia Liefshitz; Martin Kupiec
Journal:  EMBO J       Date:  2004-11-18       Impact factor: 11.598

View more
  32 in total

1.  A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy.

Authors:  Karl A Merrick; Sandra Morandell; Chang-Qi Zhu; Ian G Cannell; Christian J Braun; Robert A Grant; Eleanor R Cameron; Ming-Sound Tsao; Michael T Hemann; Michael B Yaffe
Journal:  Cancer Cell       Date:  2015-11-09       Impact factor: 31.743

Review 2.  Bistable switches as integrators and actuators during cell cycle progression.

Authors:  Wayne Stallaert; Katarzyna M Kedziora; Hui Xiao Chao; Jeremy E Purvis
Journal:  FEBS Lett       Date:  2019-10-16       Impact factor: 4.124

3.  Senescence induction in human fibroblasts and hematopoietic progenitors by leukemogenic fusion proteins.

Authors:  Narendra Wajapeyee; Shu-Zong Wang; Ryan W Serra; Peter D Solomon; Arvindhan Nagarajan; Xiaochun Zhu; Michael R Green
Journal:  Blood       Date:  2010-04-26       Impact factor: 22.113

4.  p27(Kip1) controls cytokinesis via the regulation of citron kinase activation.

Authors:  Murielle P Serres; Uta Kossatz; Yong Chi; James M Roberts; Nisar P Malek; Arnaud Besson
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

5.  Discovery of a pyrimidine compound endowed with antitumor activity.

Authors:  Ludovica Taglieri; Francesco Saccoliti; Alice Nicolai; Giovanna Peruzzi; Valentina Noemi Madia; Valeria Tudino; Antonella Messore; Roberto Di Santo; Marco Artico; Samanta Taurone; Maurizio Salvati; Roberta Costi; Susanna Scarpa
Journal:  Invest New Drugs       Date:  2019-03-21       Impact factor: 3.850

6.  Mechanism of T-oligo-induced cell cycle arrest in Mia-PaCa pancreatic cancer cells.

Authors:  Andrew M Rankin; Sibaji Sarkar; Douglas V Faller
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

7.  Cip2a promotes cell cycle progression in triple-negative breast cancer cells by regulating the expression and nuclear export of p27Kip1.

Authors:  H Liu; H Qiu; Y Song; Y Liu; H Wang; M Lu; M Deng; Y Gu; J Yin; K Luo; Z Zhang; X Jia; G Zheng; Z He
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

8.  MicroRNA-182-5p targets a network of genes involved in DNA repair.

Authors:  Keerthana Krishnan; Anita L Steptoe; Hilary C Martin; Shivangi Wani; Katia Nones; Nic Waddell; Mythily Mariasegaram; Peter T Simpson; Sunil R Lakhani; Brian Gabrielli; Alexander Vlassov; Nicole Cloonan; Sean M Grimmond
Journal:  RNA       Date:  2012-12-18       Impact factor: 4.942

9.  INK4a/ARF limits the expansion of cells suffering from replication stress.

Authors:  Angela Monasor; Matilde Murga; Andres J Lopez-Contreras; Carolina Navas; Gonzalo Gomez; David G Pisano; Oscar Fernandez-Capetillo
Journal:  Cell Cycle       Date:  2013-05-15       Impact factor: 4.534

10.  WIP1 dephosphorylation of p27Kip1 Serine 140 destabilizes p27Kip1 and reverses anti-proliferative effects of ATM phosphorylation.

Authors:  Byung-Kwon Choi; Kenichiro Fujiwara; Tajhal Dayaram; Yolanda Darlington; Joshua Dickerson; Margaret A Goodell; Lawrence A Donehower
Journal:  Cell Cycle       Date:  2020-01-20       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.